iBio Inc (AMEX:IBIO) price on Wednesday, March 27, rose 192.17% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.36.
A look at the stock’s price movement, the close in the last trading session was $1.15. The beta value (5-Year monthly) was -3.80. Turning to its 52-week performance, $49.80 and $1.02 were the 52-week high and 52-week low respectively. Overall, IBIO moved 187.18% over the past month.
iBio Inc’s market cap currently stands at around $11.69 million, with investors looking forward to this quarter’s earnings report slated for May 13, 2024 – May 17, 2024.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that IBIO is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
IBIO’s current price about 191.86% and 191.83% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 94.08, while 7-day volatility ratio is 17.56% and 8.03% in the 30-day chart. Further, iBio Inc (IBIO) has a beta value of -3.80, and an average true range (ATR) of 0.26.
If we refocus on iBio Inc (AMEX:IBIO), historical trading data shows that trading volumes averaged 16.95 million over the past 10 days and 106.81K over the past 3 months. The company’s latest data on shares outstanding shows there are 3.48 million shares.
The 0.39% of iBio Inc’s shares are in the hands of company insiders while institutional holders own 7.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.11 million on Feb 29, 2024, giving us a short ratio of 0.95. The data shows that as of Feb 29, 2024 short interest in iBio Inc (IBIO) stood at 3.08% of shares outstanding, with shares short rising to 4610.0 registered in Jan 31, 2024. Current price change has pushed the stock 145.26% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IBIO stock continues to rise going into the next quarter.
